Results 111 to 120 of about 68,105 (186)
Clinical management of a severe skull fracture in a loggerhead sea turtle (Caretta caretta)
Abstract A 30.6 kg loggerhead sea turtle (Caretta caretta) presented with a 2–3‐week‐old deep head wound, left neck and right cubital lacerations, and carapace fractures. Haematology revealed a marked leukocytosis, with other values unremarkable. Initial wound‐cleaning, an antibiotic course, fluids and vitamin B supplementation were initiated. Computed
Madeline Yde +4 more
wiley +1 more source
Metabolic mechanism of ceftazidime resistance in Vibrio alginolyticus
Shi-Rao Liu,1 Xuan-Xian Peng,1,2 Hui Li1 1Center for Proteomics and Metabolomics, State Key Laboratory of Biocontrol, Guangdong Province Key Laboratory for Pharmaceutical Functional Genes, School of Life Sciences, Sun Yat-sen University, University City,
Li H, Liu SR, Peng XX
core
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run
Background: Therapeutic drug monitoring (TDM) is becoming an increasingly recommended approach for assessing optimal pharmacokinetic/pharmacodynamic (PK/PD) target attainment of ceftazidime/avibactam.
Gatti, Milo +2 more
core +1 more source
Molecular markers ceftazidime treatment in vivo.
Molecular markers ceftazidime treatment in vivo.
Jason E. Cummings (2803606) +1 more
core +1 more source
ABSTRACT Systemic antibiotics are effective when used as adjunctive therapy in the treatment of periodontitis; however, their use must be balanced against antimicrobial resistance, which is a major threat to global public health. This review provides an expert synthesis of the literature and a field‐level overview of antimicrobial resistance in ...
Meera Alghafri +3 more
wiley +1 more source
Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and some Ambler class D enzymes. This review summarizes the existing data published for ceftazidime-
Hoban, Daryl J. +11 more
core +1 more source
Neurotoxicity manifested as confusion and seizures has been recognized as a side effect of multiple cephalosporins including ceftazidime. Renal impairment and inappropriate dosing are the most common contributors to the development of neurological ...
Romy Rodriguez Ortega +4 more
core +1 more source
We performed a proof-of-concept study to validate a peptide-conjugated peptide nucleic acid (PPNA) directed to inhibit peptidoglycan recycling as strategy to reduce AmpC hyperproduction and β-lactam resistance in Pseudomonas aeruginosa.
Maria Escobar-Salom +7 more
doaj +1 more source
Ceftazidime in the treatment of febrile immunosuppressed children
We carried out a pilot study using ceftazidime alone in the treatment of febrile, neutropenic children. A total of 16 episodes were treated before the study was re-evaluated and tobramycin was added.
Williamson, P J +5 more
core +1 more source
Ceftazidime is widely used off-label to treat neonatal infections, underscoring the need for optimized dosing strategies. However, pharmacokinetic (PK) studies in neonates are limited by the challenges of conventional blood sampling.
Qiufen Yin +8 more
doaj +1 more source

